To reduce the risk of cardiovascular death and hospitalization in adults with heart failure.
Active substances:
Sacubitril
Valsartan
Therapeutic effects:
Sacubitril inhibits neprilysin, increasing levels of peptides (such as natriuretic peptides) to help control blood volume.
Valsartan blocks the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently.
Contraindications:
Do not take if you are allergic to Sacubitril, Valsartan, or any other ingredients.
Do not take if you have had a reaction called angioedema (swelling of the face, lips, tongue, and throat, and difficulties in breathing).
Do not take if you have diabetes or impaired kidney function and are being treated with a blood pressure-lowering medicine containing Aliskiren.
Do not take if you have severe liver disease, are pregnant, or breastfeeding.
Warnings and precautions:
Inform your doctor if you are taking any other heart medicines before starting this medicine.
Tell your doctor if you have low blood pressure, severe kidney disease, dehydration, liver disease, hallucinations, or changes in your sleeping pattern.
Do not store above 25°C.
Store in the original package to protect from light.
Keep the medicine away from the reach of children and pets.
Dosage and administration:
Always take this medicine exactly as your doctor or pharmacist has told you.
Swallow the tablets with a glass of water.
You can take Valentas 200mg Tablet with or without food.
Do not crush, chew, or split the tablets.
Safety advice:
Pregnancy: do not take if you are pregnant because it may cause harm to the unborn baby.
Breastfeeding: breastfeeding is not recommended in patients taking Valentas 200mg Tablet.
Lungs: consult your doctor if you have any lung diseases before starting the treatment.
Liver: Valentas 200mg Tablet should be cautiously given in patients with liver problems.
Alcohol: it is unknown whether consuming alcohol is safe during the treatment with Valentas 200mg Tablet.
Driving: Valentas 200mg Tablet can make you feel tired, dizzy, or sleepy. Do not drive or operate heavy machinery if this medicine affects you.
Serious: kidney damage, angioedema (swelling of the face, lips, tongue and throat, and difficulties in breathing).
FAQs:
What is Valentas 200mg Tablet?
Valentas 200mg Tablet is a combination medication for treating heart failure in adult patients. It contains two active ingredients, sacubitril, and valsartan, which work together to improve heart function and reduce the risk of hospitalization and cardiovascular deaths.
What are the common side effects of Valentas 200mg Tablet?
Common side effects of Valentas 200mg Tablet may include low blood pressure, dizziness, increased heart rate, cough, and elevated potassium levels in the blood. It is important to report any unusual or severe side effects to your healthcare provider.
Is regular monitoring required during Valentas 200mg Tablet treatment?
Regular monitoring of blood pressure, kidney function, and potassium levels may be required during Valentas 200mg Tablet treatment. Your healthcare provider will determine the appropriate monitoring schedule based on your needs.
Can I take Valentas 200mg Tablet with or without food?
The combination of valsartan and sacubitril is a tablet to take by mouth. Take the tablet as prescribed by your doctor. It is usually taken with or without food. To help you remember to take the combination of valsartan and sacubitril, take it at around the same times every day.
Can Valentas 200mg Tablet interact with other medications?
Valentas 200mg Tablet may interact with certain medications and cause undesirable side effects. It is important to inform your healthcare provider about all your medications to avoid potential drug interactions. Inform your physician if you are taking medications containing Aliskiren.
Fact box:
Molecule name: Sacubitril + Valsartan
Therapeutic class: Cardiovascular agents
Pharmacological class:
Sacubitril - Neprilysin Inhibitors
Valsartan - Angiotensin II receptor antagonist
Indications: To reduce the risk of cardiovascular events due to heart failure